Recurrent hypoglycaemia leads to impairment in glucagon‐mediated hepatic glycogenolysis in type 1 diabetic mice
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Min-Ne Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Key Laboratory of Universities in Shandong Province, Shandong Second Medical University, Weifang, China. Hauptthemen laut MEDLINE: Glucagon, Hypoglycemia, Diabetes Mellitus, Type 1, Glycogenolysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
To explore the alterations in pancreatic α cells and hepatic glycogen metabolism in mice with type 1 diabetes mellitus (T1DM) following recurrent hypoglycaemia, aiming to elucidate the underlying mechanisms that contribute to impaired counterregulatory responses to hypoglycaemia. Materials/Methods The alterations in pancreatic α cells and hepatic glycogenolysis were assessed in T1DM mice experiencing recurrent hypoglycaemia induced by insulin. Furthermore, glucagon intervention experiments were conducted on T1DM mice subjected to recurrent hypoglycaemia and on their primary hepatocytes to clarify further the mechanisms responsible for the observed changes in hepatic glycogenolysis.
Results
In T1DM mice, recurrent hypoglycaemia led to a reduction of pancreatic α cell mass and a decrease in glucagon synthesis and secretion by these cells, indicating a compromised counterregulatory response to hypoglycaemia. Furthermore, repeated hypoglycaemic episodes disrupted hepatic glycogenolysis, thereby diminishing the liver's ability to respond to hypoglycaemia. The observed decrease in the expression of hepatic glucagon receptors was closely associated with the impairment of hepatic glycogenolysis, ultimately leading to a reduced hyperglycaemic effect of exogenous glucagon.
Conclusions
Pancreatic α cells play a significant role in developing hypoglycaemic counterregulatory impairment induced by recurrent hypoglycaemia; however, the liver's role is even more critical. Recurrent hypoglycaemia can lead to a reduction in the expression of glucagon receptors in the liver, resulting in impaired hypoglycaemic counterregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Key Laboratory of Universities in Shandong Province, Shandong Second Medical University, Weifang, China.
- Morphology Laboratory, Shandong Second Medical University, Weifang, China.
ORCID-Profile: Min-Ne Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, M. N., Jin, F. X., Zhao, J. J., Wang, Y., Zhuang, B. X., & Li, R. J. (2025). Recurrent hypoglycaemia leads to impairment in glucagon‐mediated hepatic glycogenolysis in type 1 diabetic mice. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16409
Vancouver
Li MN, Jin FX, Zhao JJ, Wang Y, Zhuang BX, Li RJ. Recurrent hypoglycaemia leads to impairment in glucagon‐mediated hepatic glycogenolysis in type 1 diabetic mice. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16409
BibTeX
@article{Li2025,
author = {Li, Min-Ne and Jin, Fang-Xin and Zhao, Jing-Jing and Wang, Yan and Zhuang, Bao-Xiang and Li, Ru-Jiang},
title = {Recurrent hypoglycaemia leads to impairment in glucagon‐mediated hepatic glycogenolysis in type 1 diabetic mice},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16409}
}
EUVIMED